Semler Scientific Inc. logo

Semler Scientific Inc. (6FA)

Market Open
8 Dec, 07:12
16. 50
+0.5
+3.12%
- Market Cap
17.58 P/E Ratio
0% Div Yield
0 Volume
2.65 Eps
16
Previous Close
Day Range
16.5 16.5
Year Range
14.8 73.5
Want to track 6FA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 70 days

Summary

6FA trading today higher at €16.5, an increase of 3.12% from yesterday's close, completing a monthly decrease of -7.3% or €1.3. Over the past 12 months, 6FA stock lost -67.33%.
6FA is not paying dividends to its shareholders.
The last earnings report, released on Nov 12, 2025, exceeded the consensus estimates by 0.14%. On average, the company has surpassed earnings expectations by 0.07%, based on the last three reports. The next scheduled earnings report is due on Feb 16, 2026.
The stock of the company had never split.
The company's stock is traded on 7 different exchanges and in various currencies, with the primary listing on NASDAQ (CM) (USD).

6FA Chart

Strive: Strategic Expansion Meets Bitcoin Tailwinds -- Set For A Solid 2025 Finish

Strive: Strategic Expansion Meets Bitcoin Tailwinds -- Set For A Solid 2025 Finish

Strive Asset Management, LLC is acquiring Semler Scientific, boosting its Bitcoin holdings to 10,900 coins and becoming a top-12 BTC treasury company. The all-stock deal offers a 210% premium to SMLR shareholders and creates a combined entity with $1.25 billion in Bitcoin at current prices. ASST trades at a 24% discount to its pro forma Bitcoin holdings, supporting a bullish outlook and a 12-month price target of $1.70 (23% upside).

Seekingalpha | 1 month ago
Semler Scientific, Inc. (SMLR) Q2 2025 Earnings Call Transcript

Semler Scientific, Inc. (SMLR) Q2 2025 Earnings Call Transcript

Semler Scientific, Inc. (NASDAQ:SMLR ) Q2 2025 Earnings Conference Call August 4, 2025 4:30 PM ET Company Participants Douglas Murphy-Chutorian - CEO, President & Director Eric H. Semler - Executive Chairman of the Board Joe Burnett - Corporate Participant Renae Cormier - CFO, Head of Corp. Communications & Bus.

Seekingalpha | 4 months ago
Semler Scientific, Inc. (SMLR) Q1 2025 Earnings Call Transcript

Semler Scientific, Inc. (SMLR) Q1 2025 Earnings Call Transcript

Semler Scientific, Inc. (NASDAQ:SMLR ) Q1 2025 Earnings Conference Call May 13, 2025 4:00 PM ET Company Participants Doug Murphy-Chutorian - CEO Eric Semler - Chairman Jennifer Oliva Herrington - COO Renae Cormier - CFO Operator Good afternoon and welcome to the Semler Scientific First Quarter 2025 Financial Results Conference Call. All participants will be in a listen-only mode.

Seekingalpha | 6 months ago

Semler Scientific Inc. (6FA) FAQ

What is the stock price today?

The current price is €16.50.

On which exchange is it traded?

Semler Scientific Inc. is listed on NASDAQ (CM).

What is its stock symbol?

The ticker symbol is 6FA.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, no market cap data is available.

When is the next earnings date?

The next earnings report will release on Feb 16, 2026.

Has Semler Scientific Inc. ever had a stock split?

No, there has never been a stock split.

Semler Scientific Inc. Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Douglas Murphy-Chutorian CEO
XDUS Exchange
US81684M1045 ISIN
US Country
79 Employees
- Last Dividend
- Last Split
21 Feb 2014 IPO Date

Overview

Semler Scientific, Inc., based in Santa Clara, California, is a technology company focused on providing advanced solutions to enhance the clinical operations and effectiveness of healthcare providers across the United States. Incorporated in 2007, Semler Scientific lays emphasis on innovating and distributing products that aid in the assessment and management of vascular conditions and diabetes care. Their client base encompasses a wide range of healthcare professionals and organizations, including cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as healthcare insurance plans, integrated delivery networks, independent physician groups, and companies in the healthcare industry such as risk assessment groups and retailers. Distribution is achieved through a combination of direct sales representatives and distributors, ensuring their cutting-edge products are accessible to a broad spectrum of healthcare providers.

Products and Services

  • QuantaFlo:

    This product stands out as a quick and efficient in-office test designed to measure blood flow, taking only about four minutes to complete. QuantaFlo's technology enables healthcare providers to easily incorporate blood flow measurements into their examination process, aiding in the assessment of a patient's vascular health. This tool is particularly useful for professionals aiming to diagnose and manage vascular conditions with greater accuracy and speed.

  • Insulin Insights:

    A sophisticated software program, Insulin Insights is crafted to assist healthcare providers in optimizing insulin dosing for outpatients. By utilizing this tool, medical practitioners can achieve more precise and individualized insulin dose recommendations, enhancing the overall management of diabetes. This program underscores Semler Scientific's commitment to supporting healthcare providers in delivering better diabetes care, by leveraging advanced technology to improve treatment outcomes for patients.

Contact Information

Address: 2340-2348 Walsh Avenue
Phone: 877-774-4211